STOP PRESS: News in brief

HEALTHCARE: Pfizer has handed the PR account to promote its

anti-depressant Lustral to Galliard Healthcare Communications. PR was

previously carried out in-house. Galliard is already handling the UK

pre-launch PR for the Pfizer anti-psychotic drug Ziprasidone.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.